Renalytix

0 followers


Renalytix (LSE: RENX) (NASDAQ: RNLX) is the founder and global leader in the new field of bioprognosis™ for kidney health.

Industries

Headquarters

Stage

Employees

Links

Org chart

James McCullough

Collapse
Steven Coca
Co-Founder
Michael J. Donovan
Chief Medical Officer
Jed Fulk
Vice President Of Sales
Shelley Glick
Vice President
Anna Flynn
Director, Quality System Compliance And Eh&s
Elise Wilfinger
Senior Vice President, Global Brand Strategy & Marketing Officer
Anita M.
Lab Technical Supervisor
Azadeh Zabetian
Senior Medical Science Liaison
Christopher Woytovich
Clinical Laboratory Scientist (cls)
Ilya Fligelman
Laboratory Group Lead
Katherine Edwards PhD
Senior R&d Scientist
Noor Alyassin, MD
Research Assistant
Kate Brennan, CFA
Senior Manager, Strategic Finance
Andria Parks-Herrera
Vice President, Sales Operations & Analytics
Christopher Scott
SVP, Operations